The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial
Clinical trial NCT06050577 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06050577
- Sponsor
- Odense University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-07
- Primary completion
- 2026-01-15
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.